These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8165527)

  • 21. A combination treatment for localized prostate cancer.
    Mayo Clin Health Lett; 2005 Feb; 23(2):4. PubMed ID: 15732168
    [No Abstract]   [Full Text] [Related]  

  • 22. The management of end-stage carcinoma of the prostate: philosophy and fact.
    Robinson MR
    Prog Clin Biol Res; 1990; 357():39-44. PubMed ID: 2217476
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined radiotherapy and hormone therapy in non-metastatic adenocarcinoma of prostate].
    Lopez S; Simon JM; Mazeron JJ
    Bull Cancer; 2009 Mar; 96(3):261-70. PubMed ID: 19318304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Pollack A; Horwitz EM
    Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
    Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radiotherapy combined with hormonal therapy as treatment method in patients with prostate cancer: still more questions than answers].
    Milecki P
    Przegl Lek; 2005; 62(12):1455-9. PubMed ID: 16786772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indications of the association of radiotherapy and hormonal treatment in prostate cancer].
    Bolla M; Maingon P; Fourneret P; Artignan X; Descotes JL
    Cancer Radiother; 2005 Nov; 9(6-7):394-8. PubMed ID: 16226044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endocrine therapy for localized or locally advanced prostate cancer].
    Fontaine E; Ruffion A; Staerman F
    Prog Urol; 2004 Jun; 14(3):433-6. PubMed ID: 15373195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High risk prostate cancer results of one year RT-HT].
    Delaporte V; Muracciole X; Lechevalier E; Bastide C; Cowen D; Rossi D; Coulange C
    Prog Urol; 2005 Dec; 15(6 Suppl 1):1256-61. PubMed ID: 16734214
    [No Abstract]   [Full Text] [Related]  

  • 30. Treating prostate cancer: another step forward.
    Harv Mens Health Watch; 1998 May; 2(10):7. PubMed ID: 9577263
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate-only not dead?
    Chuba PJ; Aref A
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):329-30. PubMed ID: 16377423
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Ohlmann C; Heidenreich A
    Aktuelle Urol; 2004 Sep; 35(5):372-4. PubMed ID: 15478268
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical strategies for improving the radiotherapeutic management of prostate cancer.
    Chuba PJ; Forman JD; Ben-Josef E; Hart KH; Porter AT
    Anticancer Res; 1997; 17(3A):1449-54. PubMed ID: 9179182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External beam radiotherapy for prostate cancer: current position and trends.
    Koukourakis MI; Touloupidis S
    Anticancer Res; 2006; 26(1B):485-94. PubMed ID: 16739309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperative clinical trials in prostate cancer.
    Murphy GP; Slack NH
    Prog Clin Biol Res; 1981; 75B():341-6. PubMed ID: 7323102
    [No Abstract]   [Full Text] [Related]  

  • 36. Combining external beam radiotherapy with prostate brachytherapy: issues and rationale.
    Febles C; Valicenti RK
    Urology; 2004 Nov; 64(5):855-61. PubMed ID: 15533463
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
    Scalliet P
    Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.
    Woodward WA; Wachsberger P; Burd R; Dicker AP
    Prostate Cancer Prostatic Dis; 2005; 8(2):127-32. PubMed ID: 15643450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer.
    Jani AB; Gratzle J; Myers M
    Prostate Cancer Prostatic Dis; 2005; 8(3):224-8. PubMed ID: 15983626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer: non-metastatic.
    Wilt T
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.